Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xingxing Su
PUM1 Knockdown Prevents Tumor Progression by Activating the PERK/eIF2/ATF4 Signaling Pathway in Pancreatic Adenocarcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Rifampicin Protects PC12 Cells From Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2α-ATF4 Pathway
PLoS ONE
Multidisciplinary
Activation of the PERK-ATF4 Pathway Promotes Chemo-Resistance in Colon Cancer Cells
Scientific Reports
Multidisciplinary
Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating P38 MAPK Signaling Pathway
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
CTHRC1 Overexpression Promotes Cervical Carcinoma Progression by Activating the WNT/PCP Signaling Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
SLPI Knockdown Induced Pancreatic Ductal Adenocarcinoma Cells Proliferation and Invasion
Cancer Cell International
Cancer Research
Oncology
Genetics
Cell Division Cycle Associated 5 Promotes Colorectal Cancer Progression by Activating the ERK Signaling Pathway
Oncogenesis
Cancer Research
Molecular Biology
Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
Cancer Research
Cancer Research
Oncology
MEX3A Knockdown Inhibits the Development of Pancreatic Ductal Adenocarcinoma
Cancer Cell International
Cancer Research
Oncology
Genetics
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway
Molecular Cancer Therapeutics
Cancer Research
Oncology